Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRVL vs GSK✓SelectedUSD · GSKMRVL vs GSK performance historyLatest closeAs of-2.15%11/18
Stock and ETF performance explorer

MRVL vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+85.3%
GSK return
+7.0%
Excess return
+78.3%
Maximum drawdown
-57.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.2%-1.3%-0.8%-2.5%
7D-13.8%-3.1%-10.7%-14.6%
30D-38.6%-0.9%-37.7%-38.5%
3M-32.6%-4.2%-28.4%-32.4%
6M-13.8%-1.6%-12.2%-13.9%
YTD+71.6%+2.6%+69.0%+71.4%
1Y+85.3%+6.2%+79.1%+80.6%
All+85.3%+7.0%+78.3%+80.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling